PROSUS NV (PRX.AS) Fundamental Analysis & Valuation

AMS:PRX • NL0013654783

Current stock price

38.72 EUR
-0.78 (-1.97%)
Last:

This PRX.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. PRX.AS Profitability Analysis

1.1 Basic Checks

  • In the past year PRX was profitable.
  • In the past year PRX had a positive cash flow from operations.
  • In the past 5 years PRX has always been profitable.
  • The reported operating cash flow has been mixed in the past 5 years: PRX reported negative operating cash flow in multiple years.
PRX.AS Yearly Net Income VS EBIT VS OCF VS FCFPRX.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

1.2 Ratios

  • PRX's Return On Assets of 16.85% is amongst the best of the industry. PRX outperforms 92.31% of its industry peers.
  • With an excellent Return On Equity value of 24.24%, PRX belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
  • PRX has a worse Return On Invested Capital (0.27%) than 69.23% of its industry peers.
Industry RankSector Rank
ROA 16.85%
ROE 24.24%
ROIC 0.27%
ROA(3y)14.42%
ROA(5y)16.58%
ROE(3y)20.97%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
PRX.AS Yearly ROA, ROE, ROICPRX.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

1.3 Margins

  • With an excellent Profit Margin value of 196.38%, PRX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • PRX's Profit Margin has improved in the last couple of years.
  • PRX has a worse Operating Margin (3.87%) than 61.54% of its industry peers.
  • Looking at the Gross Margin, with a value of 45.21%, PRX is in line with its industry, outperforming 46.15% of the companies in the same industry.
  • PRX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.87%
PM (TTM) 196.38%
GM 45.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.61%
PM growth 5Y12.1%
GM growth 3Y20.87%
GM growth 5Y4.2%
PRX.AS Yearly Profit, Operating, Gross MarginsPRX.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300 400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. PRX.AS Health Analysis

2.1 Basic Checks

  • PRX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • PRX has less shares outstanding than it did 1 year ago.
  • PRX has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for PRX has been reduced compared to a year ago.
PRX.AS Yearly Shares OutstandingPRX.AS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
PRX.AS Yearly Total Debt VS Total AssetsPRX.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • PRX has an Altman-Z score of 3.88. This indicates that PRX is financially healthy and has little risk of bankruptcy at the moment.
  • PRX has a Altman-Z score of 3.88. This is in the better half of the industry: PRX outperforms 69.23% of its industry peers.
  • The Debt to FCF ratio of PRX is 9.30, which is on the high side as it means it would take PRX, 9.30 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 9.30, PRX perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
  • PRX has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
  • PRX has a Debt to Equity ratio of 0.30. This is in the better half of the industry: PRX outperforms 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.3
Altman-Z 3.88
ROIC/WACC0.04
WACC7.11%
PRX.AS Yearly LT Debt VS Equity VS FCFPRX.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B 40B 50B

2.3 Liquidity

  • PRX has a Current Ratio of 3.66. This indicates that PRX is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of PRX (3.66) is better than 92.31% of its industry peers.
  • A Quick Ratio of 3.62 indicates that PRX has no problem at all paying its short term obligations.
  • PRX has a Quick ratio of 3.62. This is amongst the best in the industry. PRX outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.66
Quick Ratio 3.62
PRX.AS Yearly Current Assets VS Current LiabilitesPRX.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. PRX.AS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 87.14% over the past year.
  • The Earnings Per Share has been growing by 17.24% on average over the past years. This is quite good.
  • The Revenue has grown by 16.28% in the past year. This is quite good.
  • Measured over the past years, PRX shows a quite strong growth in Revenue. The Revenue has been growing by 13.13% on average per year.
EPS 1Y (TTM)87.14%
EPS 3Y-3.39%
EPS 5Y17.24%
EPS Q2Q%35.96%
Revenue 1Y (TTM)16.28%
Revenue growth 3Y-0.36%
Revenue growth 5Y13.13%
Sales Q2Q%22.27%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.73% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 16.04% on average over the next years. This is quite good.
EPS Next Y28.2%
EPS Next 2Y23.26%
EPS Next 3Y20.67%
EPS Next 5Y11.73%
Revenue Next Year38.16%
Revenue Next 2Y31.7%
Revenue Next 3Y25.85%
Revenue Next 5Y16.04%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PRX.AS Yearly Revenue VS EstimatesPRX.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
PRX.AS Yearly EPS VS EstimatesPRX.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

7

4. PRX.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 7.65, the valuation of PRX can be described as very cheap.
  • Based on the Price/Earnings ratio, PRX is valued cheaper than 100.00% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 24.88. PRX is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 8.95, the valuation of PRX can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, PRX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • PRX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.19.
Industry RankSector Rank
PE 7.65
Fwd PE 8.95
PRX.AS Price Earnings VS Forward Price EarningsPRX.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • 76.92% of the companies in the same industry are cheaper than PRX, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, PRX is valued a bit cheaper than 61.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 55.62
EV/EBITDA 291.35
PRX.AS Per share dataPRX.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • PRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as PRX's earnings are expected to grow with 20.67% in the coming years.
PEG (NY)0.27
PEG (5Y)0.44
EPS Next 2Y23.26%
EPS Next 3Y20.67%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. PRX.AS Dividend Analysis

5.1 Amount

  • PRX has a yearly dividend return of 0.51%, which is pretty low.
  • The stock price of PRX dropped by -26.08% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • PRX's Dividend Yield is a higher than the industry average which is at 0.57.
  • Compared to an average S&P500 Dividend Yield of 1.89, PRX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.51%

5.2 History

  • The dividend of PRX decreases each year by -19.73%.
Dividend Growth(5Y)-19.73%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • PRX pays out 2.00% of its income as dividend. This is a sustainable payout ratio.
DP2%
EPS Next 2Y23.26%
EPS Next 3Y20.67%
PRX.AS Yearly Income VS Free CF VS DividendPRX.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B
PRX.AS Dividend Payout.PRX.AS Dividend Payout, showing the Payout Ratio.PRX.AS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

PRX.AS Fundamentals: All Metrics, Ratios and Statistics

PROSUS NV

AMS:PRX (3/27/2026, 7:00:00 PM)

38.72

-0.78 (-1.97%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)11-24
Earnings (Next)N/A
Inst Owners64.94%
Inst Owner ChangeN/A
Ins Owners0.75%
Ins Owner ChangeN/A
Market Cap92.11B
Revenue(TTM)6.83B
Net Income(TTM)13.41B
Analysts80
Price Target67.72 (74.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.51%
Yearly Dividend0.04
Dividend Growth(5Y)-19.73%
DP2%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.06%
PT rev (3m)0.09%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)4.13%
EPS NY rev (3m)7.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)4.79%
Revenue NY rev (3m)4.79%
Valuation
Industry RankSector Rank
PE 7.65
Fwd PE 8.95
P/S 15.56
P/FCF 55.62
P/OCF 52.78
P/B 1.92
P/tB 2.06
EV/EBITDA 291.35
EPS(TTM)5.06
EY13.07%
EPS(NY)4.33
Fwd EY11.17%
FCF(TTM)0.7
FCFY1.8%
OCF(TTM)0.73
OCFY1.89%
SpS2.49
BVpS20.16
TBVpS18.76
PEG (NY)0.27
PEG (5Y)0.44
Graham Number47.91
Profitability
Industry RankSector Rank
ROA 16.85%
ROE 24.24%
ROCE 0.36%
ROIC 0.27%
ROICexc 0.29%
ROICexgc 0.3%
OM 3.87%
PM (TTM) 196.38%
GM 45.21%
FCFM 27.98%
ROA(3y)14.42%
ROA(5y)16.58%
ROE(3y)20.97%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.61%
PM growth 5Y12.1%
GM growth 3Y20.87%
GM growth 5Y4.2%
F-Score7
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.3
Debt/EBITDA 40.19
Cap/Depr 70.55%
Cap/Sales 1.51%
Interest Coverage 0.46
Cash Conversion 491.22%
Profit Quality 14.25%
Current Ratio 3.66
Quick Ratio 3.62
Altman-Z 3.88
F-Score7
WACC7.11%
ROIC/WACC0.04
Cap/Depr(3y)83.48%
Cap/Depr(5y)79.69%
Cap/Sales(3y)2.75%
Cap/Sales(5y)2.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.14%
EPS 3Y-3.39%
EPS 5Y17.24%
EPS Q2Q%35.96%
EPS Next Y28.2%
EPS Next 2Y23.26%
EPS Next 3Y20.67%
EPS Next 5Y11.73%
Revenue 1Y (TTM)16.28%
Revenue growth 3Y-0.36%
Revenue growth 5Y13.13%
Sales Q2Q%22.27%
Revenue Next Year38.16%
Revenue Next 2Y31.7%
Revenue Next 3Y25.85%
Revenue Next 5Y16.04%
EBIT growth 1Y576.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year372.25%
EBIT Next 3Y107.05%
EBIT Next 5Y139.61%
FCF growth 1Y289.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y217.17%
OCF growth 3YN/A
OCF growth 5YN/A

PROSUS NV / PRX.AS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for PROSUS NV?

ChartMill assigns a fundamental rating of 6 / 10 to PRX.AS.


Can you provide the valuation status for PROSUS NV?

ChartMill assigns a valuation rating of 7 / 10 to PROSUS NV (PRX.AS). This can be considered as Undervalued.


Can you provide the profitability details for PROSUS NV?

PROSUS NV (PRX.AS) has a profitability rating of 5 / 10.


What is the earnings growth outlook for PROSUS NV?

The Earnings per Share (EPS) of PROSUS NV (PRX.AS) is expected to grow by 28.2% in the next year.


How sustainable is the dividend of PROSUS NV (PRX.AS) stock?

The dividend rating of PROSUS NV (PRX.AS) is 3 / 10 and the dividend payout ratio is 2%.